All companies, by net margin
508 companies and 2246 sets of results: the S&P 500, and sometimes a company from outside it. We can draw the statement for 418.
| # | Company | Market cap | Share price | Net margin | Quarter |
|---|---|---|---|---|---|
| 251 |
|
$35.5B | $340.32 +8.3% | 28% Last four quarters 2026: Q1, Q2, Q3 · 2025: Q4 | Q3 FY26 CBOE Cboe Global Markets |
| 252 | EQT S&P 500 EQT Position 252 S&P 500 Share price: $55.15 +1.1% Q3 FY26 EQT EQT | $34.5B | $55.15 +1.1% | 28% Last four quarters 2026: Q1, Q2, Q3 · 2025: Q4 | Q3 FY26 EQT EQT |
| 253 |
|
$19.9B | $38.56 +3.4% | 28% Last four quarters 2026: Q1, Q2 · 2025: Q3, Q4 | Q2 FY26 FIS Fidelity National Information Services |
| 254 |
|
$167B | $190.80 −12.6% | 28% Last four quarters 2027: Q1, Q2 · 2026: Q3, Q4 | Q2 FY27 MRVL Marvell Technology |
| 255 |
|
$33.3B | $230.98 −8.6% | 28% Last four quarters 2027: Q1 · 2026: Q2, Q3, Q4 | Q1 FY27 RMD ResMed |
| 256 |
|
$92.4B | $59.29 −2.2% | 28% Last four quarters 2026: Q1, Q2 · 2025: Q3, Q4 | Q2 FY26 USB U.S. Bancorp |
| 257 |
|
$33.1B | $80.02 +2.2% | 28% Last four quarters 2026: Q1, Q2 · 2025: Q3, Q4 | Q2 FY26 ZTS Zoetis |
| 258 |
|
$99.2B | $135.24 −2.8% | 29% Last four quarters 2026: Q1, Q2, Q3 · 2025: Q4 | Q3 FY26 FTNT Fortinet |
| 259 |
|
$94.1B | $914.09 +11.6% | 29% Last four quarters 2026: Q1, Q2, Q3 · 2025: Q4 | Q3 FY26 REGN Regeneron Pharmaceuticals |
| 260 |
|
$11.5B | $35.76 +1.0% | 29% Last four quarters 2026: Q1 · 2025: Q2, Q3, Q4 | Q1 FY26 UDR UDR |
| 261 |
|
$180B | $302.56 +0.2% | 29% Last four quarters 2026: Q1, Q2, Q3 · 2025: Q4 | Q3 FY26 UNP Union Pacific |
| 262 |
|
$50.4B | $310.21 +0.0% | 29% Last four quarters 2027: Q1, Q2 · 2026: Q3, Q4 | Q2 FY27 VEEV Veeva Systems |
| 263 |
|
$25.7B | $197.40 +3.5% | 29% Last four quarters 2026: Q1 · 2025: Q2, Q3, Q4 | Q1 FY26 VRSK Verisk Analytics |
| 264 |
|
$197B | $407.20 −6.0% | 30% Last four quarters 2026: Q1, Q2, Q3 · 2025: Q4 | Q3 FY26 ADI Analog Devices |
| 265 |
|
$304B | $383.59 −9.0% | 30% Last four quarters 2026: Q1, Q2, Q3 · 2025: Q4 | Q3 FY26 AMAT Applied Materials |
| 266 | ASML outside the index ASML Position 266 outside the index Share price: $1,537.73 −8.2% Q2 FY26 ASML ASML | – | $1,537.73 −8.2% | 30% Last four quarters 2026: Q1, Q2 · 2025: Q3, Q4 | Q2 FY26 ASML ASML |
| 267 |
|
$95.0B | $169.15 +3.7% | 30% Last four quarters 2026: Q1, Q2, Q3 · 2025: Q4 | Q3 FY26 ICE Intercontinental Exchange |
| 268 |
|
$258B | $61.96 −0.1% | 30% Last four quarters 2026: Q1, Q2, Q3 · 2025: Q4 | Q3 FY26 NFLX Netflix |
| 269 | ROP S&P 500 Roper Technologies Position 269 S&P 500 Share price: $467.80 +4.0% Q2 FY26 ROP Roper Technologies | $46.3B | $467.80 +4.0% | 30% Last four quarters 2026: Q1, Q2 · 2025: Q3, Q4 | Q2 FY26 ROP Roper Technologies |
| 270 |
|
$90.7B | $227.30 −2.0% | 31% Last four quarters 2026: Q1, Q2 · 2025: Q3, Q4 | Q2 FY26 PNC PNC Financial Services |
| 271 |
|
$28.1B | $30.33 +2.6% | 32% Last four quarters 2026: Q1, Q2, Q3, Q4 | Q4 FY26 CPRT Copart |
| 272 |
|
$256B | $880.44 −5.1% | 32% Last four quarters 2026: Q1, Q2 · 2025: Q3, Q4 | Q2 FY26 GS Goldman Sachs |
| 273 |
|
$1.34T | $1,422.89 +3.6% | 32% Last four quarters 2026: Q1, Q2, Q3 · 2025: Q4 | Q3 FY26 LLY Eli Lilly |
| 274 |
|
$292B | $233.05 −8.4% | 32% Last four quarters 2027: Q1 · 2026: Q2, Q3, Q4 | Q1 FY27 LRCX Lam Research |
| 275 |
|
$184B | $259.49 +0.8% | 32% Last four quarters 2026: Q1, Q2 · 2025: Q3, Q4 | Q2 FY26 MCD McDonald's |
New results in your inbox
When a big company reports, we send you a link to its diagram before anyone has time to comment on it. This is a mailing list, not an account: it does not open the diagrams by itself. No spam, one-click unsubscribe.